Aspiriant LLC’s Vanguard Morningstar Small-Cap Value ETF VBR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$424M Buy
1,745,538
+6,009
+0.3% +$1.4M 10.47% 2
2026
Q1
$378M Buy
1,739,529
+118,821
+7% +$26.6M 10.76% 2
2025
Q4
$343M Buy
1,620,708
+93,408
+6% +$19.6M 9.86% 3
2025
Q3
$319M Buy
1,527,300
+43,846
+3% +$8.97M 9.75% 3
2025
Q2
$289M Sell
1,483,454
-57,978
-4% -$10.7M 9.19% 3
2025
Q1
$287M Buy
1,541,432
+317,301
+26% +$62.7M 9.97% 3
2024
Q4
$243M Buy
1,224,131
+362,906
+42% +$74.5M 8.76% 5
2024
Q3
$173M Buy
861,225
+40,354
+5% +$7.76M 6.56% 6
2024
Q2
$150M Buy
820,871
+67,776
+9% +$12.5M 6.11% 6
2024
Q1
$145M Buy
753,095
+2,309
+0.3% +$417K 5.98% 6
2023
Q4
$135M Buy
750,786
+25,950
+4% +$4.24M 6.09% 5
2023
Q3
$116M Buy
724,836
+1,262
+0.2% +$211K 5.92% 5
2023
Q2
$120M Buy
723,574
+14
+0% +$2.2K 6.05% 5
2023
Q1
$115M Sell
723,560
-5,930
-0.8% -$982K 6.01% 5
2022
Q4
$116M Sell
729,490
-51,601
-7% -$8.22M 5.9% 5
2022
Q3
$112M Sell
781,091
-20,133
-3% -$3.2M 5.48% 5
2022
Q2
$120M Sell
801,224
-25,744
-3% -$4.22M 5.79% 5
2022
Q1
$146M Sell
826,968
-29,444
-3% -$5.12M 8% 3
2021
Q4
$153M Sell
856,412
-47,616
-5% -$8.47M 8.19% 3
2021
Q3
$153M Sell
904,028
-287,979
-24% -$49.3M 8.99% 3
2021
Q2
$207M Buy
1,192,007
+88,730
+8% +$15.4M 11.7% 2
2021
Q1
$183M Buy
1,103,277
+17,773
+2% +$2.8M 11.67% 2
2020
Q4
$154M Buy
1,085,504
+670,762
+162% +$86.5M 10.53% 2
2020
Q3
$45.9M Buy
414,742
+5,471
+1% +$613K 3.59% 9
2020
Q2
$43.7M Sell
409,271
-29,641
-7% -$2.97M 4.06% 8
2020
Q1
$39M Buy
438,912
+102,408
+30% +$12.4M 3.84% 8
2019
Q4
$46.1M Buy
336,504
+106,644
+46% +$14.1M 4.27% 5
2019
Q3
$29.7M Buy
229,860
+228,328
+14,904% +$29.2M 2.66% 10
2019
Q2
$200K Sell
1,532
-235
-13% -$30.6K 0.02% 225
2019
Q1
$228K Sell
1,767
-193
-10% -$24.5K 0.02% 208
2018
Q4
$223K Buy
1,960
+522
+36% +$66K 0.02% 214
2018
Q3
$201K Buy
+1,438
New +$202K 0.02% 230
2017
Q4
Sell
-1,776
Closed -$227K 177
2017
Q3
$227K Buy
+1,776
New +$219K 0.02% 187
2017
Q1
Sell
-2,117
Closed -$256K 226
2016
Q4
$256K Sell
2,117
-2,760
-57% -$317K 0.02% 169
2016
Q3
$540K Buy
+4,877
New +$535K 0.05% 133
2015
Q4
Sell
-10,359
Closed -$1.09M 97
2015
Q3
$1.09M Buy
10,359
+2,163
+26% +$224K 0.09% 53
2015
Q2
$884K Buy
8,196
+2,706
+49% +$297K 0.09% 55
2015
Q1
$601K Sell
5,490
-930
-14% -$98.7K 0.08% 54
2014
Q4
$679K Buy
6,420
+2,177
+51% +$224K 0.09% 50
2014
Q3
$423K Hold
4,243
0.06% 65
2014
Q2
$448K Sell
4,243
-3,987
-48% -$403K 0.06% 66
2014
Q1
$828K Sell
8,230
-1,072
-12% -$105K 0.12% 58
2013
Q4
$906K Buy
9,302
+5,000
+116% +$472K 0.14% 42
2013
Q3
$388K Sell
4,302
-5,000
-54% -$442K 0.07% 39
2013
Q2
$779K Buy
+9,302
New +$772K 0.12% 39

Other funds holding VBR

Aspiriant LLC's VBR Position: Q2 2026 in Review

Aspiriant LLC increased its Vanguard Morningstar Small-Cap Value ETF (VBR) stake by 0.35% in Q2 2026, buying an estimated $1.4M and bringing the position to 1,745,538 shares worth $424M. The position accounts for 10.47% of the portfolio, ranked #2.

Aspiriant LLC first reported a position in VBR in Q2 2013 and has held it in 45 quarters since. 1,761 funds tracked by Wall St. Rank hold VBR as of Q2 2026.

  • Aspiriant LLC held 1,745,538 shares of Vanguard Morningstar Small-Cap Value ETF worth $424M as of Q2 2026.
  • Aspiriant LLC bought 6,009 Vanguard Morningstar Small-Cap Value ETF shares in Q2 2026, an estimated $1.4M.
  • Vanguard Morningstar Small-Cap Value ETF made up 10.47% of Aspiriant LLC's portfolio in Q2 2026, its #2 holding.
  • Aspiriant LLC first reported a position in Vanguard Morningstar Small-Cap Value ETF in Q2 2013 and has held it in 45 quarters since.
  • 1,761 funds tracked by Wall St. Rank held Vanguard Morningstar Small-Cap Value ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.